Literature DB >> 30117266

Overlapping radiofrequency ablation planning and robot-assisted needle insertion for large liver tumors.

Ping Liu1,2, Jing Qin3, Bin Duan4, Qiong Wang1, Xiaoyu Tan4, Baoliang Zhao1, Peneyra Libao Jonnathan5, Chee-Kong Chui4, Pheng-Ann Heng1,6.   

Abstract

BACKGROUND: We aimed at facilitating percutaneous radiofrequency ablation (RFA) for large tumors with accurate overlapping ablation planning and robot-assisted needle insertion from a single incision port (SIP).
METHODS: We developed a personalized and quantitative RFA planning method to obtain multiple needle overlapping ablation planning through a single incision. A robot with a remote center of motion mechanism was designed to perform needle insertions through a SIP according to the planning.
RESULTS: Numerical and visual evaluation showed that the planning could yield nearly full coverage over large tumors and greatly reduce both ablation times and the ablations of normal tissues. Ex vivo and in vivo experiments showed that our robot-assisted needle insertion system was capable of conducting the RFA procedure in large liver tumors from a SIP.
CONCLUSIONS: Robot-assisted RFA needle insertions from a SIP makes RFA treatment for large tumors more minimally invasive, predictable, and repeatable.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ablation planning; large tumor; robot-assisted needle insertion; single incision

Mesh:

Year:  2018        PMID: 30117266     DOI: 10.1002/rcs.1952

Source DB:  PubMed          Journal:  Int J Med Robot        ISSN: 1478-5951            Impact factor:   2.547


  2 in total

1.  Robot-assisted flexible needle insertion using universal distributional deep reinforcement learning.

Authors:  Xiaoyu Tan; Yonggu Lee; Chin-Boon Chng; Kah-Bin Lim; Chee-Kong Chui
Journal:  Int J Comput Assist Radiol Surg       Date:  2019-11-25       Impact factor: 2.924

2.  Transcatheter arterial chemoembolization combined with simultaneous cone beam computed tomography-guided multipolar microwave ablation for massive hepatocellular carcinoma (≥10 cm): Safety and primary clinical results.

Authors:  Xiongying Jiang; Xue Han; Tianqi Zhang; Zhimei Huang; Jingxian Shen; Yajun Bo; Guiqun Chen; Minshan Chen; Jinhua Huang
Journal:  J Interv Med       Date:  2019-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.